Company Name
Cyclacel Pharmaceuticals Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN:
US23254L6039
CIK:
0001130166
CUSIP:
23254L603
Currency:
USD
Full Time Employees:
0
Phone:
60 9 08517 7330
Website:
https://www.cyclacel.com
Fiscal Year End:
December
IPO Date:
May 05, 2004
Description:
Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops cancer medicines based on cell cycle, transcriptional regulation, epigenetics, and mitosis control biology in the United States. Its lead product Plogosertib or plogo, a solid tumors and hematological malignancies, which is in Phase 1/2 clinical trial. The company was founded in 1996 and is headquartered in Kuala Lumpur, Malaysia.
Address:
Level 10, Kuala Lumpur, Malaysia, 592000